Gold and silver were seeing some profit-taking to kick off the final week of 2025, but the bond market has been an "island of calm," according to Bob Savage, head of markets macro strategy at BNY. The ...

The Halda deal aims to bolster the healthcare company's oncology pipeline. With the buy, Johnson & Johnson adds to its portfolio Halda's lead candidate, HLD-0915, a once-daily therapy for prostate ...

Silver’s parabolic rally has taken the precious metal to a level that historically signals a meaningful move lower is ahead, ...

Ultragenyx Pharmaceutical and Mereo BioPharma said their two Phase 3 trials for setrusumab to treat rare bone disorder osteogenesis imperfecta, didn't meet their main goal of reducing fracture rates.

The Cboe Volatility Index, also known as the "VIX" or Wall Street's "fear gauge," spiked Monday morning after touching its lowest level in more than a year last week. The VIX was up 9% at 14.83 ...

In just three years, generative artificial intelligence has gone from a fringe Silicon Valley novelty to a household name.

AI-related capital investment has reached approximately $400 billion in 2025. Next year’s estimates coincide north of $500 ...

Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor.

Alphabet took the title as this year’s top-performing ‘Magnificent Seven’ stock, but the AI competition is fierce ...

I have a very modest sum in my CD, checking, and savings accounts (approximately $150,000). I have set up a payable on death ...

Here are some of the stocks making notable moves in Monday's premarket action: Shares of DigitalBridge are up 32% after Bloomberg News reported that [SoftBank is nearing a deal to buy the manager of ...

These 10 ideas targeting affordability will be tested in 2026. Which ones could help people who are struggling — and which ...